Literature DB >> 21109987

Involvement of let-7/miR-98 microRNAs in the regulation of progesterone receptor membrane component 1 expression in ovarian cancer cells.

Alexandra Wendler1, Daniela Keller, Christian Albrecht, John J Peluso, Martin Wehling.   

Abstract

PGRMC1 (progesterone receptor membrane component 1) is part of a multi-protein complex, that is highly expressed in several cancers and is involved in chemoresistance. Although PGRMC1 plays an important role in various cancers, little is known about how PGRMC1 expression is regulated. Therefore, the present study was designed to elucidate the molecular mechanisms that influence PGRMC1 expression in ovarian cancer cells. An in silico approach revealed that the 3'-untranslated region of PGRMC1 contains one highly and one poorly conserved binding site for the microRNA let-7/miR-98 and one highly conserved binding site for miR-141/200a. Luciferase assays and real-time PCRs showed that the let-7 isoforms let-7i and miR-98 target PGRMC1 in SKOV-3 cells. In contrast, the conserved binding site for miR-200a/141 in the 3'-UTR of PGRMC1 is not functional. Stimulation of SKOV-3 cells with progesterone resulted in a decrease in PGRMC1 mRNA levels. Further, an analysis of endogenous let-7i levels in SKOV-3 cells revealed that let-7i expression increased after stimulation with progesterone. Therefore, progesterone may exert its effect on PGRMC1 expression in part by stimulation of let-7i. In conclusion, we propose that PGRMC1 expression is regulated by the miRNAs let-7/miR-98, which could become therapeutic targets, as PGRMC1, like many other targets of let-7, seems to be involved in cancer proliferation and chemotherapy resistance.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21109987

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  28 in total

1.  MiR-98 inhibits malignant progression via targeting MTDH in squamous cell carcinoma of the head and neck.

Authors:  Haolei Tan; Gangcai Zhu; Li She; Ming Wei; Yunyun Wang; Leiming Pi; Changhan Chen; Diekuo Zhang; Pingqing Tan; Jie Chen; Donghai Huang; Yongquan Tian; Yong Liu; Xin Zhang
Journal:  Am J Cancer Res       Date:  2017-12-01       Impact factor: 6.166

2.  Upregulation of TRB2 induced by miR-98 in the early lesions of large artery of type-2 diabetic rat.

Authors:  Shuyang Xie; Ning Xie; Youjie Li; Pingyu Wang; Chao Zhang; Qiang Li; Xiaolin Liu; Jingti Deng; Can Zhang; Changjun Lv
Journal:  Mol Cell Biochem       Date:  2011-10-20       Impact factor: 3.396

Review 3.  Understanding the CREB1-miRNA feedback loop in human malignancies.

Authors:  Ya-Wen Wang; Xu Chen; Rong Ma; Peng Gao
Journal:  Tumour Biol       Date:  2016-04-09

4.  The Effect of miR-98 and miR-214 on Apoptotic and Angiogenic Pathways in Hepatocellular Carcinoma HepG2 Cells.

Authors:  Shaymaa M M Yahya; Shereen M M Yahya
Journal:  Indian J Clin Biochem       Date:  2019-03-11

5.  Let-7i inhibition enhances progesterone-induced functional recovery in a mouse model of ischemia.

Authors:  Trinh Nguyen; Chang Su; Meharvan Singh
Journal:  Proc Natl Acad Sci U S A       Date:  2018-09-20       Impact factor: 11.205

6.  Copy-number gains of HUWE1 due to replication- and recombination-based rearrangements.

Authors:  Guy Froyen; Stefanie Belet; Francisco Martinez; Cíntia Barros Santos-Rebouças; Matthias Declercq; Jelle Verbeeck; Lene Donckers; Siren Berland; Sonia Mayo; Monica Rosello; Márcia Mattos Gonçalves Pimentel; Natalia Fintelman-Rodrigues; Randi Hovland; Suely Rodrigues dos Santos; F Lucy Raymond; Tulika Bose; Mark A Corbett; Leslie Sheffield; Conny M A van Ravenswaaij-Arts; Trijnie Dijkhuizen; Charles Coutton; Veronique Satre; Victoria Siu; Peter Marynen
Journal:  Am J Hum Genet       Date:  2012-07-26       Impact factor: 11.025

7.  Progesterone receptor membrane component 1 deficiency attenuates growth while promoting chemosensitivity of human endometrial xenograft tumors.

Authors:  Anne M Friel; Ling Zhang; Cindy A Pru; Nicole C Clark; Melissa L McCallum; Leen J Blok; Toshi Shioda; John J Peluso; Bo R Rueda; James K Pru
Journal:  Cancer Lett       Date:  2014-10-07       Impact factor: 8.679

8.  Endometrial miR-181a and miR-98 expression is altered during transition from normal into cancerous state and target PGR, PGRMC1, CYP19A1, DDX3X, and TIMP3.

Authors:  Harekrushna Panda; Tsai-Der Chuang; Xiaoping Luo; Nasser Chegini
Journal:  J Clin Endocrinol Metab       Date:  2012-04-06       Impact factor: 5.958

9.  miRNA-Based Therapeutic Strategies.

Authors:  Masaharu Ishida; Florin M Selaru
Journal:  Curr Anesthesiol Rep       Date:  2012-12-24

Review 10.  Role of microRNAs in chemoresistance.

Authors:  Peter Magee; Lei Shi; Michela Garofalo
Journal:  Ann Transl Med       Date:  2015-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.